The swift delivery of the world's first COVID-19 vaccine put a spotlight on the potential of mRNA technology and has opened new doors for vaccine development. mRNA-based vaccines for a variety of diseases are now being researched, including potential new vaccines for flu.
Both COVID-19 and flu continue to be an area of critical need for public health globally. Millions of cases of illness are attributed to these two viruses each year and they can be life-threatening for many individuals. Receiving the recommended COVID-19 boosters and an annual flu vaccine is the best strategy for protecting yourself and others from serious illness.
Currently, COVID-19 boosters and the annual flu vaccine are given as separate vaccines. Advances in mRNA technology could make it possible to combine a COVID-19 booster with the annual flu vaccine into a single shot.
A combined vaccine would be more convenient and accessible for most people. This could help increase vaccination rates and provide greater protection against both of these infectious diseases.